Regulon

Regulon: R-1736

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
252.5857812Pr-38Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7204 ENSG00000038382 TRIO O75962
28951 ENSG00000071575 TRIB2 Q92519
3842 ENSG00000083312 TNPO1 Q92973
2734 ENSG00000090863 GLG1 Q92896
7976 ENSG00000104290 FZD3 Q9NPG1
2887 ENSG00000106070 GRB10 Q13322
2034 ENSG00000116016 EPAS1 Q99814
1647 ENSG00000116717 GADD45A P24522
23314 ENSG00000119042 SATB2 Q9UPW6
2181 ENSG00000123983 ACSL3 O95573
643314 ENSG00000127603 MACF1 B4DQX9
10631 ENSG00000133110 POSTN Q15063
10253 ENSG00000136158 SPRY2 O43597
9805 ENSG00000136193 SCRN1 Q12765
10427 ENSG00000138802 SEC24B O95487
1848 ENSG00000139318 DUSP6 Q16828
357 ENSG00000146950 SHROOM2 Q13796
10252 ENSG00000164056 SPRY1 O43609
9529 ENSG00000166170 BAG5 A0A024R6M6
55584 ENSG00000174343 CHRNA9 Q9UGM1
9435 ENSG00000175040 CHST2 Q9Y4C5
81848 ENSG00000187678 SPRY4 Q9C004
3556 ENSG00000196083 IL1RAP Q9NPH3
200734 ENSG00000198369 SPRED2 Q7Z698
25907 ENSG00000249992 TMEM158 Q8WZ71

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
IMSIDOLIMABIL1RL2AntibodyANTAGONISTIL36 receptor antagonist20
BELZUTIFANEPAS1Small moleculeINHIBITOREndothelial PAS domain-containing protein 1 inhibitor40
NERAMEXANEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30
NERAMEXANE MESYLATEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30
SPESOLIMABIL1RL2AntibodyANTAGONISTIL36 receptor antagonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1736

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-17879TGM3down-regulatesPOU2F2repressesR-1736141Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

IMSIDOLIMAB, BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB

CMF-26826VAV1down-regulatesPOU2F2repressesR-1736142Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

IMSIDOLIMAB, BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE, SPESOLIMAB